HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Orthostatic effects of midodrine versus L-NAME on cerebral blood flow and the renin-angiotensin-aldosterone system in tetraplegia.

AbstractOBJECTIVE:
To compare responses to head-up tilt (HUT) in individuals with chronic tetraplegia after midodrine hydrochloride (10 mg) versus nitro-L-arginine methyl ester (L-NAME, 1 mg/kg) administration.
DESIGN:
Prospective comparative drug trial.
SETTING:
Veterans Affairs medical center.
PARTICIPANTS:
Participants (N=7) were studied during 3 laboratory visits: no drug, midodrine (administered orally 30 min before HUT), and L-NAME (infused over a 60-min period).
INTERVENTIONS:
Anti-hypotensive agents, midodrine, and L-NAME.
MAIN OUTCOME MEASURES:
Mean arterial pressure (MAP), cerebral blood flow (CBF), and markers of the renin-angiotensin-aldosterone system (RAAS, plasma renin and serum aldosterone) were measured in the supine position at baseline (BL) and during a 45° HUT maneuver. Data were compared between BL and the average of 3 assessments collected during HUT.
RESULTS:
Orthostatic MAP and CBF were increased with the midodrine and L-NAME groups compared with the no drug trial and the relationship between the change in MAP and CBF was significant (r=0.770; P<0.001). Both L-NAME and midodrine appeared to suppress the post-HUT RAAS response compared with no drug.
CONCLUSIONS:
Increasing orthostatic blood pressure with L-NAME or midodrine appears to increase CBF and suppress the RAAS during HUT in persons with tetraplegia, although more data are needed to confirm these preliminary findings.
AuthorsJill M Wecht, Miroslav Radulovic, Dwindally Rosado-Rivera, Run-Lin Zhang, Michael F LaFountaine, William A Bauman
JournalArchives of physical medicine and rehabilitation (Arch Phys Med Rehabil) Vol. 92 Issue 11 Pg. 1789-95 (Nov 2011) ISSN: 1532-821X [Electronic] United States
PMID21762873 (Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
CopyrightCopyright © 2011 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Vasoconstrictor Agents
  • Midodrine
  • NG-Nitroarginine Methyl Ester
Topics
  • Adult
  • Cerebrovascular Circulation (drug effects)
  • Dizziness (chemically induced)
  • Female
  • Hemodynamics (drug effects)
  • Humans
  • Male
  • Middle Aged
  • Midodrine (pharmacology)
  • NG-Nitroarginine Methyl Ester (pharmacology)
  • Physical Therapy Modalities
  • Prospective Studies
  • Quadriplegia (drug therapy)
  • Renin-Angiotensin System (drug effects)
  • United States
  • United States Department of Veterans Affairs
  • Vasoconstrictor Agents (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: